Glasgow Chemistry Firm DeepMatter in Merck deal

Glasgow-based DeepMatter Group plc, the AIM-listed company focusing on digitizing chemistry, announced that one of its wholly owned subsidiaries has entered into a multi-year, limited-use data licensing agreement with the life science business of Merck to provide “proprietary chemical structure and reaction data content to Merck’s selected application.”

The terms of the data license agreement have not been disclosed.

DeepMatter CEO Mark Warne said: “We are delighted to have entered into this license with Merck, a company dedicated to making research and biotech simpler, faster and safer.”

About the Author

Mark McSherry
Dalriada Media LLC sites are edited by veteran news journalist Mark McSherry, a former staff editor and reporter with Reuters, Bloomberg and major newspapers including the South China Morning Post, London's Sunday Times and The Scotsman. McSherry's journalism has also appeared in The Washington Post, The Guardian, The Independent, The New York Times, London's Evening Standard and Forbes. McSherry is also a professor of journalism and communication arts in universities and colleges in New York City. Scottish-born McSherry has an MBA from the University of Edinburgh and a Certificate in Global Affairs from New York University.